As a highly focused research-driven biopharmaceutical company, AbbVie takes on the toughest health challenges. But we do more than treat diseases - we aim to make a remarkable impact on people's lives. The AbbVie Press Kit is designed to provide journalists with a broad range of background information on our company. If you are a member of the news media and have questions or need additional information, please contact our Communications Team.


Sep 21, 2018

AbbVie and Family Reach Donation Impact Press Kit

On Sept. 21, 2018, AbbVie announced a $5 million donation to Family Reach, a national nonprofit dedicated to supporting family-centered care by developing and sharing actionable financial solutions for families facing a pediatric cancer diagnosis. Our collaboration is grounded in the belief that a patient’s chance of overcoming cancer should never be jeopardized by financial barriers.
Aug 20, 2018

AbbVie and RMHC Donation Impact Press Kit

On Aug. 20, 2018, AbbVie announced a historic $100 million donation to Ronald McDonald House Charities (RMHC) to support hospitalized children and their families. This gift will provide housing and family-centered services for pediatric patients and their families during hospital treatment across the United States.
Jul 24, 2018

Endometriosis Press Kit

Endometriosis Press Kit
Jul 09, 2018

AbbVie Corporate Press Kit

AbbVie is a research-based global biopharmaceutical company committed to developing innovative, advanced therapies for some of the world's most complex and critical conditions. The company's mission is to use its expertise, dedicated people and unique approach to innovation to markedly improve treatments across four primary therapeutic areas: immunology, oncology, virology and neuroscience, as well as general medicine.